NZ218028A - Benzimidazole derivatives and pharmaceutical compositions - Google Patents

Benzimidazole derivatives and pharmaceutical compositions

Info

Publication number
NZ218028A
NZ218028A NZ218028A NZ21802886A NZ218028A NZ 218028 A NZ218028 A NZ 218028A NZ 218028 A NZ218028 A NZ 218028A NZ 21802886 A NZ21802886 A NZ 21802886A NZ 218028 A NZ218028 A NZ 218028A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
benzimidazole derivatives
compounds
benzimidazole
derivatives
Prior art date
Application number
NZ218028A
Other languages
English (en)
Inventor
T B Alminger
H S Larsson
P L Lindberg
G E Sunden
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of NZ218028A publication Critical patent/NZ218028A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NZ218028A 1985-10-29 1986-10-22 Benzimidazole derivatives and pharmaceutical compositions NZ218028A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8505112A SE8505112D0 (sv) 1985-10-29 1985-10-29 Novel pharmacological compounds

Publications (1)

Publication Number Publication Date
NZ218028A true NZ218028A (en) 1990-02-26

Family

ID=20361960

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ218028A NZ218028A (en) 1985-10-29 1986-10-22 Benzimidazole derivatives and pharmaceutical compositions

Country Status (31)

Country Link
US (1) US5021433A (forum.php)
EP (2) EP0233284B1 (forum.php)
JP (2) JPH0780874B2 (forum.php)
KR (1) KR950009858B1 (forum.php)
CN (1) CN1022487C (forum.php)
AT (1) ATE79619T1 (forum.php)
AU (1) AU598491B2 (forum.php)
CS (1) CS272767B2 (forum.php)
DD (1) DD252375A5 (forum.php)
DE (1) DE3686483T2 (forum.php)
DK (1) DK320587A (forum.php)
EG (1) EG17753A (forum.php)
ES (1) ES2051696T3 (forum.php)
FI (1) FI91151C (forum.php)
GR (1) GR3006177T3 (forum.php)
HU (1) HU198474B (forum.php)
IE (1) IE59167B1 (forum.php)
IL (1) IL80437A0 (forum.php)
IS (1) IS1564B (forum.php)
JO (1) JO1502B1 (forum.php)
LT (1) LTIP1681A (forum.php)
LV (1) LV10270B (forum.php)
MY (1) MY101791A (forum.php)
NO (1) NO171365C (forum.php)
NZ (1) NZ218028A (forum.php)
PH (1) PH25319A (forum.php)
PL (1) PL150240B1 (forum.php)
PT (1) PT83647B (forum.php)
SE (1) SE8505112D0 (forum.php)
WO (1) WO1987002668A1 (forum.php)
ZA (1) ZA867716B (forum.php)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222495A (en) * 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
US5175286A (en) * 1988-09-20 1992-12-29 Hisamitsu Pharmaceutical Co., Inc. Dibenz[b,e]oxepin derivatives
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
IE64199B1 (en) * 1988-12-22 1995-07-12 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
US5049674A (en) * 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
AU649456B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
ES2048109B1 (es) * 1992-07-20 1994-12-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados piperidicos del bencimidazol.
WO1995032957A1 (en) * 1994-05-27 1995-12-07 Astra Aktiebolag Novel ethoxycarbonyloxymethyl derivatives of substituted benzimidazoles
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
CA2338311C (en) 1998-08-10 2007-01-23 Michael E. Garst Prodrugs of the pyridyl methyl sulfinyl benzimidazoles
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6369087B1 (en) * 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US20040039027A1 (en) * 2000-10-12 2004-02-26 Keiji Kamiyama Benzimidazole compounds, process for producing the same and use thereof
US20040248941A1 (en) * 2001-09-25 2004-12-09 Keiji Kamiyama Benzimidazone compound, process for producing the same, and use thereof
EP1513527B1 (en) * 2002-06-14 2009-07-29 Takeda Pharmaceutical Company Limited Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
JP4463103B2 (ja) * 2002-07-19 2010-05-12 ウィンストン・ファーマシューティカルズ・リミテッド・ライアビリティ・カンパニー ベンズイミダゾール誘導体およびプロトンポンプ阻害剤のプロドラッグとしてのその使用
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US20060241037A1 (en) * 2003-10-03 2006-10-26 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump ihhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
EP1715854A2 (en) * 2004-02-18 2006-11-02 Allergan, Inc. Prodrugs for the intravenous administration of proton pump inhibitors
CA2556756A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
US20050239845A1 (en) * 2004-04-16 2005-10-27 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
PT1740571E (pt) * 2004-04-28 2009-09-02 Hetero Drugs Ltd Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
ES2338556T3 (es) 2004-05-28 2010-05-10 Hetero Drugs Limited Sintesis estereoselectiva novedosa de sulfoxidos de benzimidazol.
US8394409B2 (en) * 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CA2648280C (en) * 2006-04-03 2014-03-11 Isa Odidi Controlled release delivery device comprising an organosol coat
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008036201A1 (en) * 2006-09-19 2008-03-27 Alevium Pharmaceuticals, Inc. Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
ES2768295T3 (es) * 2010-01-07 2020-06-22 Alkermes Pharma Ireland Ltd Profármacos de compuestos heteroaromáticos

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
US4045564A (en) * 1974-02-18 1977-08-30 Ab Hassle Benzimidazole derivatives useful as gastric acid secretion inhibitors
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
IN148930B (forum.php) * 1977-09-19 1981-07-25 Hoffmann La Roche
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
ZA856671B (en) * 1984-09-24 1986-04-30 Upjohn Co N-substituted derivatives of 2-(pyridylaklenesulfinyl)benzimidazoles as gastric antisecretory agents

Also Published As

Publication number Publication date
NO171365C (no) 1993-03-03
HU198474B (en) 1989-10-30
DE3686483D1 (de) 1992-09-24
EP0233284A1 (en) 1987-08-26
IS3156A7 (is) 1987-04-30
IS1564B (is) 1994-12-13
FI872864L (fi) 1987-06-29
ATE79619T1 (de) 1992-09-15
FI91151B (fi) 1994-02-15
IL80437A0 (en) 1987-01-30
IE862805L (en) 1987-04-29
EP0221041A3 (en) 1987-10-28
DE3686483T2 (de) 1993-02-04
DD252375A5 (de) 1987-12-16
LV10270A (lv) 1994-10-20
EP0221041A2 (en) 1987-05-06
US5021433A (en) 1991-06-04
AU6542986A (en) 1987-05-19
NO872686D0 (no) 1987-06-26
KR950009858B1 (ko) 1995-08-29
PL262105A1 (en) 1988-08-18
ZA867716B (en) 1987-05-27
EG17753A (en) 1991-12-30
NO171365B (no) 1992-11-23
NO872686L (no) 1987-06-26
CN86107595A (zh) 1987-07-08
IE59167B1 (en) 1994-01-12
PL150240B1 (en) 1990-05-31
PH25319A (forum.php) 1991-04-30
MY101791A (en) 1992-01-31
HUT43843A (en) 1987-12-28
SE8505112D0 (sv) 1985-10-29
LTIP1681A (en) 1995-09-25
KR870700620A (ko) 1987-12-30
JPH0780874B2 (ja) 1995-08-30
GR3006177T3 (forum.php) 1993-06-21
EP0233284B1 (en) 1992-08-19
ES2051696T3 (es) 1994-07-01
JO1502B1 (en) 1989-01-25
CS272767B2 (en) 1991-02-12
DK320587D0 (da) 1987-06-24
WO1987002668A1 (en) 1987-05-07
FI91151C (sv) 1994-05-25
PT83647B (pt) 1989-05-31
FI872864A0 (fi) 1987-06-29
DK320587A (da) 1987-06-24
JPH07188216A (ja) 1995-07-25
PT83647A (en) 1986-11-01
AU598491B2 (en) 1990-06-28
JPS63501151A (ja) 1988-04-28
JPH0826014B2 (ja) 1996-03-13
CN1022487C (zh) 1993-10-20
CS782686A2 (en) 1990-05-14
LV10270B (en) 1995-04-20

Similar Documents

Publication Publication Date Title
NZ218028A (en) Benzimidazole derivatives and pharmaceutical compositions
IE873125L (en) Benzimidazole derivatives
SE8700499D0 (sv) Novel pharmacologically active compounds
IL89840A0 (en) Substituted flavonoid compounds and salts thereof,their preparation and pharmaceutical compositions containing them
SE8404065D0 (sv) Novel biologically active compounds
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
EP0321968A3 (en) Compounds active on the cardiovascular system
SE8600658D0 (sv) Novel composition of matter
EP0321967A3 (en) Compounds active on the cardiovascular system
JO1519B1 (en) New compounds (new benzimidazole derivatives are effective as ulcers)
JO1531B1 (en) New near-compounds